Letters Global access to vaccines

Poor nations are being lured into a debt trap

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39563.529757.BE (Published 01 May 2008) Cite this as: BMJ 2008;336:974
  1. Jacob M Puliyel, consultant paediatrician and head of department,
  2. Ashutosh Shrivastava, resident in paediatrics
  1. 1St Stephen’s Hospital, Tis Hazari, Delhi 110054, India
  1. puliyel{at}gmail.com

    With regard to access to papillomavirus vaccine (Gardasil),1 let us assume that the vaccine covers all strains causing cervical cancer. In India 21m girls would have to be vaccinated each year to avoid 260 000 deaths at a cost for the vaccine alone of $8400m. The programme would have to be sustained for over 20 years. Even if it prevented all cervical cancers, it would reduce by only 2% the 10.9m deaths caused by infectious …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe